TimKeutzer's profile picture. Pharma exec, husband, father, he/him

Tim Keutzer

@TimKeutzer

Pharma exec, husband, father, he/him

Tim Keutzer reposted

Spero has been named one of Boston's Best Places to Work by @BosBizJournal! At Spero, we believe that our Sperobes are our most important & valued resource. We pride ourselves on working together to advance new #RareDisease and #InfectiousDiseases therapies. #BBJBPTW

Spero_Tx's tweet image. Spero has been named one of Boston's Best Places to Work by @BosBizJournal! At Spero, we believe that our Sperobes are our most important & valued resource. We pride ourselves on working together to advance new #RareDisease and #InfectiousDiseases therapies. #BBJBPTW

Proud to be part of this team, and happy for tebipenem HBr’s path forward! s3.amazonaws.com/b2icontent.irp…


Tim Keutzer reposted

Professor William Hope @APTlivuni has been awarded an OBE for services to the Centre of Excellence in Infectious Diseases Research (CEIDR), infectious diseases and COVID-19. 👏 #QueensBirthdayHonours ➡️ bit.ly/35dI0KI @LiverpoolCEIDR @LivUniISMIB @LivHospitals

livuninews's tweet image. Professor William Hope @APTlivuni has been awarded an OBE for services to the Centre of Excellence in Infectious Diseases Research (CEIDR), infectious diseases and COVID-19. 👏 #QueensBirthdayHonours

➡️ bit.ly/35dI0KI
@LiverpoolCEIDR @LivUniISMIB @LivHospitals

Tim Keutzer reposted

Finishing up another successful JP Morgan Conference and looking ahead to delivering on a number of key milestones in 2021 including submitting an NDA filing for #tebipenemHBr in 2H21. #JPM21

Spero_Tx's tweet image. Finishing up another successful JP Morgan Conference and looking ahead to delivering on a number of key milestones in 2021 including submitting an NDA filing for #tebipenemHBr in 2H21.  #JPM21

Tim Keutzer reposted

Congrats


Tim Keutzer reposted

#flu season coming during #Covid_19 epidemic - get your flu shot, wash your hands, wear a mask, watch your distance! #WeAreID @TuftsCIMAR @IDSAInfo @tufts_id


Tim Keutzer reposted

Announcing FDA acceptance of the IND application for oral #SPR720. Phase 2a clinical trial in patients with NTM pulmonary disease on track to initiate before year-end. globenewswire.com/news-release/2…


Loading...

Something went wrong.


Something went wrong.